Boston University
Kephera Diagnostics Gets $3M NIH Grant for Chagas Disease Test
The company previously received nearly $600,000 from the NIH to work on the test, which it now intends to validate in clinical studies in the US and Latin America.
Boston University, Cepheid Get FDA EUAs for COVID-19, Monkeypox Tests
The Cepheid test qualitatively detects DNA from monkeypox virus clade II and non-variola Orthopoxvirus in human lesion swab specimens.
HHS, Wellcome Commit $370M in New Funding for CARB-X
Founded in 2016, CARB-X supports the advancement of therapeutics, vaccines, rapid diagnostics, and devices to treat drug-resistant bacterial infections.
Stand Up to Cancer Launches $16.6M Effort for Early-Stage Cancer Detection, Treatment
The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.
They noted that CCL11, a protein biomarker, was significantly elevated in autopsies of American footballers diagnosed with chronic traumatic encephalopathy.